P08195 (4F2_HUMAN) Homo sapiens (Human)
Amino acid transporter heavy chain SLC3A2 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Overall structure of the LAT1-4F2hc bound with JX-075 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HNX; 2×Y01; | |||
| Overall structure of the LAT1-4F2hc bound with JX-078 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HO0; 2×Y01; | |||
| Overall structure of the LAT1-4F2hc bound with JX-119 |
Heteromer Q01650; | 100 | 4×NAG; 1×3PH; 1×HO9; 2×Y01; | |||
| Overall structure of the y+LAT1-4F2hc bound with Arg |
Heteromer Q9UM01; | 100 | 4×NAG; 1×ARG; | |||
| Local refinement of the y+LAT1-4F2hc bound with Arg |
Heteromer Q9UM01; | 100 | 4×NAG; 1×ARG; | |||
| Structure of y+LAT2 bound with Arg |
Heteromer Q92536; | 100 | 1×ARG; | |||
| Overall structure of the y+LAT2-4F2hc bound with Leu |
Heteromer Q92536; | 100 | 1×LEU; | |||
| Overall structure of the LAT1-4F2hc bound with 3,5-diiodo-L-tyrosine |
Heteromer Q01650; | 100 | 4×NAG; 1×TYI; 2×Y01; 1×3PH; | |||
| Overall structure of the LAT1-4F2hc bound with JPH203 |
Heteromer Q01650; | 100 | 4×NAG; 1×VRW; | |||
| Overall structure of the LAT1-4F2hc bound with Leu |
Heteromer Q01650; | 100 | 4×NAG; 1×LEU; | |||
| Overall structure of the LAT1-4F2hc bound with tyrosine |
Heteromer Q01650; | 100 | 4×NAG; 1×TYR; | |||
| The LAT2-4F2hc complex in complex with tryptophan |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×TRP; 2×3PH; | |||
| The LAT2-4F2hc complex in complex with leucine |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×LEU; 2×3PH; | |||
| Overall structure of the LAT1-4F2hc bound with L-dopa |
Heteromer Q01650; | 100 | 4×NAG; 1×DAH; | |||
| Overall structure of the LAT1-4F2hc bound with tryptophan |
Heteromer Q01650; | 100 | 4×NAG; 1×TRP; | |||
| Consensus mutated xCT-CD98hc complex |
Heteromer Q9UPY5; | 100 | ||||
| human LAT1-4F2hc complex incubated with JPH203 |
Heteromer Q01650; | 100 | 4×NAG; 2×3PH; | |||
| human LAT1-4F2hc complex bound with BCH |
Heteromer Q01650; | 100 | 4×NAG; 2×3PH; 1×AUU; | |||
| Cryo EM map of SLC7A10 with L-Alanine substrate |
Heteromer Q9NS82; | 100 | 1×NAG; 3×NAG; 1×ALA; | |||
| Human LAT2-4F2hc complex in the apo-state |
Heteromer Q9UHI5; | 100 | 4×NAG; 1×AJP; | |||
| Structure of apo inward-open LAT1-CD98hc-Fab170 in nanodisc, consensus map |
Heteromer Q01650; | 100 | 4×NAG; | |||
| Structure of LAT1-CD98hc-Fab170 in complex with BCH, consensus map |
Heteromer Q01650; | 100 | 4×NAG; 1×VU0; | |||
| Structure of LAT1-CD98hc-Fab170 in complex with JPH203, consensus map |
Heteromer Q01650; | 100 | 4×NAG; 1×VRW; | |||
| Structure of human Asc1/CD98hc heteromeric amino acid transporter |
Heteromer Q9NS82; | 100 | 2×NAG; 1×NAG; 1×AJP; 1×NAG; | |||
| Cryo EM map of SLC7A10 in the apo state |
Heteromer Q9NS82; | 100 | 4×NAG; | |||
| Cryo EM map of SLC7A10-SLC3A2 complex in the D-serine bound state |
Heteromer Q9NS82; | 100 | 4×NAG; 1×DSN; | |||
| Overall structure of Erastin-bound xCT-4F2hc complex |
Heteromer Q9UPY5; | 100 | 4×NAG; 1×J9O; 2×PX8; | |||
| Cryo EM structure of System XC- |
Heteromer Q9UPY5; | 100 | 4×NAG; | |||
| Human 4F2hc-LAT2 heterodimeric amino acid transporter in complex with anticalin D11vs |
Heteromer Q9UHI5; | 100 | 4×NAG; | |||
| LAT1-CD98hc complex bound to MEM-108 Fab |
Heteromer Q01650; | 100 | 1×NAG; 5×CLR; 3×NAG; | |||
| CD98hc extracellular domain bound to HBJ127 Fab and MEM-108 Fab |
Heteromer | 100 | 1×NAG; 3×NAG; | |||
| Structure of the high affinity Anticalin P3D11 in complex with the human CD98 heavy chain ectodomain |
Heteromer P80188; | 100 | 2×EDO; | |||
| Structure of complex between TV6.6 and CD98hc ECD |
Heteromer | 100.0 | 1×NAG; 5×EDO; 1×PG4; | |||
| Crystal structure of human CD98 heavy chain extracellular domain in complex with S1-F4 scFv |
Heteromer A0A5C2G3X0; | 100.0 | ||||
| Structure of apo inward-open LAT1-CD98h in nanodisc, focused on TMD |
Heteromer Q01650; | 100 | 3×CLR; 2×LBN; | |||
| Structure of LAT1-CD98hc in complex with BCH, focused on TMD |
Heteromer Q01650; | 100 | 2×CLR; 1×LBN; 1×VU0; | |||
| Structure of LAT1-CD98hc in complex with JPH203, focused on TMD |
Heteromer Q01650; | 100 | 2×CLR; 1×LBN; 1×VRW; | |||
| Structure of LAT1-CD98hc in complex with L-Phe, focused on TMD |
Heteromer Q01650; | 100 | 1×PHE; | |||
| Structure of LAT1-CD98hc in complex with melphalan, focused on TMD |
Heteromer Q01650; | 100 | 1×VUC; | |||
| Structure of apo outward-open LAT1-CD98h in nanodisc, focused on TMD |
Heteromer Q01650; | 100 | ||||
| Cryo EM structure of System XC- in complex with glutamate |
Heteromer Q9UPY5; | 100 | 1×GLU; | |||
| Crystal Structure of human ED-4F2hc | monomer | 100 | 1×ACT; | |||
| Crystal Structure of human ED-4F2hc | monomer | 100 | 1×ZN; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9kju.1.A | monomer | 0.81 | 100.00 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8a6l.1.A | monomer | 0.84 | 100.00 | |||
| Isoform 3 | 7dsn.1.A | monomer | 0.83 | 98.77 | |||
| Isoform 4 | 7dsn.1.A | monomer | 0.83 | 100.00 | |||
| Isoform 5 | 7dsn.1.A | monomer | 0.82 | 100.00 | |||